Allogeneic stem cell mobilisation

Application of the granulocyte colony-stimulating factor (G-CSF) biosimilar ratiograstim for the mobilisation of peripheral stem cells in healthy donors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN94372129

Enrollment

Registered

2012-03-30

Start date

2010-01-01

Completion date

Unknown

Last updated

2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allogeneic stem cell transplantation Surgery

Interventions

Two cohorts, one cohort of 11 patients and donors receiving the biosimilar Ratiograstim® versus another cohort of 11 patients and donors receiving reference G-CSF. Results in this study arm were compa

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Donors had no known allergy to G-CSF 2. Siblings (match-related donors)

Exclusion criteria

Exclusion criteria: Younger than 18 years

Design outcomes

Primary

Measure	Time frame
Efficacy in peripheral stem cell mobilisation	—

Secondary

Measure	Time frame
Safety in peripheral stem cell mobilisation	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026